Evidence grade BCellular energy & longevity

NAD+

Also known as Nicotinamide adenine dinucleotide, NAD therapy

A coenzyme central to cellular energy and DNA repair, given as an injectable/IV or taken as precursor supplements for energy, recovery, and healthy aging.

Evidence grade B · 7 citations · Last reviewed July 2026

Regulatory status
Not FDA-approved as a drug; administered as a compounded injectable/IV or sold as precursor supplements (NR, NMN).
Common routes
Subcutaneous injection · IV infusion · nasal · oral

Overview

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It sits at the center of energy metabolism, carrying electrons through the mitochondrial reactions that convert food into ATP, and it serves as a substrate for enzymes that repair DNA, regulate gene expression, and manage cellular stress. Without adequate NAD+, cells cannot perform these functions efficiently.

NAD+ levels fall substantially with age — by middle age, tissue concentrations may be roughly half of what they were in youth. This decline has attracted significant research attention as a potential driver of age-related metabolic dysfunction. Rather than supplementing NAD+ itself (which is poorly absorbed orally), most protocols use oral precursors — nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) — or deliver NAD+ directly by IV or subcutaneous injection. Which of the two precursors raises NAD+ more reliably is the question behind our NAD+ vs NMN vs NR comparison.

People seek NAD+ therapy for energy, mental focus, recovery support, and general longevity. It is important to frame expectations honestly: NAD+ is not a weight-loss drug, the human clinical trial evidence is still early, and the dramatic anti-aging effects seen in animal models have not been replicated in large human RCTs, as our review of human NMN and NR aging trials shows. The biology is compelling; the clinical proof of benefit in healthy adults remains incomplete.

Comparing providers? See our full ranking of NAD+ providers, scored, compared, and updated monthly.View ranking →

Where to get NAD+

Every telehealth provider we track that offers NAD+. Partners we work with are shown first.

8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
8.1/ 10
Partner

bmiMD

Best for: one flat compounded GLP-1 price at every dose: semaglutide $159/mo month to month, $119/mo on a 12-month plan

★★★★☆4.1/5

Editorial score · methodology

$159/mosemaglutide
$249/motirzepatide
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →
8.1/ 10
Partner

RxSpan MD

Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

★★★★☆4.1/5

Editorial score · methodology

$249/mosemaglutide
$329/motirzepatide
CompoundedSemaglutideTirzepatideGHK-CuGlutathioneLegitScript Verified
Get StartedRead full RxSpan MD review →
8.1/ 10
Partner

Oak

Best for: compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up

★★★★☆4.1/5

Editorial score · methodology

$200/mosemaglutide
starting dose
$250/motirzepatide
starting dose
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Oak review →
8.0/ 10
Partner

ShedRx

Best for: compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans

★★★★☆4/5

Editorial score · methodology

$199/mosemaglutide
plan-length pricing
$279/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideOrforglipronGHK-Cu
Get StartedRead full ShedRx review →
8.0/ 10
Partner

Strut Health

Best for: oral-lozenge compounded GLP-1 access

★★★★☆4/5

Editorial score · methodology

$99/mosemaglutide
“starting at” price
$149/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Strut Health review →
7.8/ 10
Partner

Embody

Best for: low flat-rate compounded GLP-1 pricing at every dose

★★★★☆3.9/5

Editorial score · methodology

$79/mosemaglutide
sale price
$129/motirzepatide
sale price
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →
7.7/ 10
Partner

Live Vital

Best for: low-cost, physician-led compounded GLP-1 with peptide and hormone options

★★★★☆3.9/5

Editorial score · methodology

$130/mosemaglutide
after intro offer
$239/motirzepatide
after intro offer
CompoundedSemaglutideTirzepatideBPC-157CJC-1295 / Ipamorelin
Get StartedRead full Live Vital review →
7.6/ 10
Partner

Sprout Health

Best for: LegitScript-certified compounded GLP-1 via named pharmacies

★★★★☆3.8/5

Editorial score · methodology

$149/4 wkssemaglutide
billed per 4 weeks
$199/4 wkstirzepatide
billed per 4 weeks
CompoundedSemaglutideTirzepatideNAD+LegitScript VerifiedFDA Warning
Get StartedRead full Sprout Health review →
7.5/ 10
Partner

Luvo Health

Best for: compounded and brand GLP-1s, oral tablets and microdosing on one public price list

★★★★☆3.8/5

Editorial score · methodology

$209/4 wkssemaglutide
billed per 4 weeks
$249/4 wkstirzepatide
billed per 4 weeks
CompoundedSemaglutideTirzepatideGonadorelinNAD+LegitScript Verified
Get StartedRead full Luvo Health review →
7.4/ 10
Partner

Brightmeds

Best for: compounded or brand GLP-1 bundled with TRT and peptides for men

★★★★☆3.7/5

Editorial score · methodology

$129/mosemaglutide
$149/motirzepatide
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Brightmeds review →
7.4/ 10
Partner

MadeMed

Best for: compounded GLP-1 in both injection and oral forms

★★★★☆3.7/5

Editorial score · methodology

$179/mosemaglutide
$249/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full MadeMed review →

Also offered by 149 more providers we track

EdenAgelessRxBodybuilding Health+PlexusDxDudeMedsSystem LabsYourEraInner BalanceDirect MedsVytora HealthEnhance MDKongoPallas HealthREMEViTyde WellnessGet Thin MDPeptiYourHealthRxPreventiveMDYucca HealthCare Bare RxKIN HealthMondaeRenlo HealthTelePeptideVitals VaultPanterra HealthRiovieRylo HealthIdgie HealthJoi + BlokesLibertyElliotMedsFresh Day MedsPepHaūsCAPO HealthObu HealthRNK HealthRxSaludableTrellis VitalityContour HealthIvologistIvy RxLevelUp RxLongevixxPeterMDTonik WellnessOurView HealthStone HealthSUROS RxAuren RxBodi EnviBreeze MedsGenesis HealthImmortalsKin MedsTelos RxIonicMDOptimized HealthTrueMeBloom MDHelloWellnessHuHealthiThriveMDLumoraNessNova MDSunlightVergeWePeptideRxKora MDMavesAZ HealthDr. Gillis' Wellness CenterEnhancedEverPrimeHalwelReadyRxThe EditBrello HealthBioverseEmbraceRXGlam HealthInvigor MedicalNativeMedNu Image MedicalNuform HealthRxION HealthRxPepsDirectTeleZen MDAquaVita NextGenRewinding RXDrBrainRxElevate HealthElitePhysiqMDHarmony Wellness ClinicHealthOnHeva HealthMANÜ TelehealthNäkyNovera MDVitaStirVyora WellnessAVArxGatlanARSYNL RxFierce HealthLevers HealthLifespanningRxLoop HealthScripts Rx DirectTrava HealthTry AgelessValhalla VitalityVitakeyAscend VitalityInstaRXLaSara Medical GroupLeland HealthModern AgeVigorMedsRegenCenLongevity MedsTRT KingdomVela RxVirgo-MedsNucificAVARA RxChiaGenesis Lifestyle MedicineHealthSourceYOURx HealthArc-1Hormonally BalancedWellMedRxGarcia Weight Loss, Aesthetics & Hormone TherapyRehydra+ WellnessIron Med RXTaurus MedsElara MDAurelius Health GroupOnyx Weight LossNeo Soma HealthcareInvyncibleVea HealthTablet HealthYouth & SoulJoey MedRemi Meds

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

How it works

NAD+ is consumed as a cofactor by two major enzyme families. Sirtuins — a class of deacylases involved in gene silencing, DNA repair, and metabolic regulation — require NAD+ to function; when NAD+ falls, sirtuin activity declines. PARPs (poly ADP-ribose polymerases) also consume NAD+ during single-strand DNA break repair: high DNA damage accelerates NAD+ depletion, potentially creating a feedback loop that impairs repair capacity over time [1][2].

Oral precursors NR and NMN enter cells via distinct transporter pathways and are enzymatically converted to NAD+ intracellularly. Both have been shown in human studies to raise blood and tissue NAD+ levels. Intravenous NAD+ delivers the coenzyme directly into circulation, bypassing gut absorption, but whether this route produces meaningfully higher tissue NAD+ — or better clinical outcomes — compared to oral precursors has not been established in published human trials.

What the evidence says

The foundational human bioavailability data come from Trammell et al. (2016, Nat Commun), who showed that a single dose of NR raised whole-blood NAD+ metabolites in healthy men, confirming that an oral precursor can meaningfully elevate NAD+ in humans [3]. This was a pharmacokinetic study, not a clinical outcomes trial, but it validated the precursor approach.

Martens et al. (2018, Nat Commun) conducted a randomized, placebo-controlled crossover trial of NR in healthy middle-aged and older adults for six weeks. NR reliably elevated blood NAD+ metabolites. However, it produced no significant improvements in blood pressure, arterial stiffness, or resting metabolic rate versus placebo — an honest null result for clinical endpoints in healthy people [4]. Similarly, Dollerup et al. (2018, Am J Clin Nutr) found in a 12-week placebo-controlled RCT that NR supplementation in obese men did not improve insulin sensitivity or skeletal muscle mitochondrial function despite raising NAD+ [7].

More promising signals emerge from specific populations. Elhassan et al. (2019, Cell Rep) found that NR supplementation augmented the NAD+ metabolome in aged human skeletal muscle and was associated with anti-inflammatory transcriptomic changes, though functional performance improvements were not statistically significant [5]. Yoshino et al. (2021, Science) reported that oral NMN (250 mg/day for 10 weeks) improved muscle insulin signaling in postmenopausal women with prediabetes and overweight — one of the most clinically specific signals in the human literature to date. Body weight did not change, and the sample size was small [6].

A broader mechanistic and preclinical review by Verdin (2015, Science) and an in vivo evidence review by Rajman et al. (2018, Cell Metab) synthesize the animal and early human data: NAD+ boosting extends healthspan in multiple animal models and attenuates metabolic disease phenotypes, but translation to humans is uncertain [1][2]. The evidence grade is B — plausible mechanism, consistent NAD+-raising effect in humans, inconsistent downstream clinical benefit in healthy adults. IV NAD+ specifically has no published controlled human trials; its use is based on mechanism and clinical anecdote.

Typical dosing

For oral precursors, clinical trials have used NR at 250–1,000 mg/day and NMN at 250–500 mg/day, typically in single or divided doses with a meal. Providers commonly use these dose ranges when prescribing oral NAD+ support. For compounded injectable or IV NAD+, clinical protocols vary widely; providers commonly use 0.5–4 mg/kg per session administered slowly to reduce infusion reactions, but no dose has been validated in a large published RCT. What a drip session costs, and whether that price buys anything, is covered in our NAD+ IV drip cost analysis.

Duration is undefined by evidence: most published human trials ran 4–12 weeks. Long-term maintenance dosing is a matter of clinical judgment rather than established evidence. Patients should discuss dosing with a licensed provider who can account for their individual health status.

Safety & side effects

Oral NR and NMN have been well tolerated in clinical trials at doses up to 1,000–2,000 mg/day for periods of weeks to months. Mild gastrointestinal effects — nausea, loose stools, or mild flushing — are the most commonly reported adverse events and typically resolve with dose adjustment. No serious adverse events have been attributed to oral NAD+ precursors in published human trials to date.

Compounded injectable and IV NAD+ are frequently reported to cause flushing, chest tightness, palpitations, and nausea, particularly when infused rapidly. These effects generally resolve with slower infusion rates. Serious adverse events from IV NAD+ have not been systematically characterized in large published trials, so the full risk profile is unknown. Compounded injectable/IV NAD+ is not FDA-approved as a drug. Use is not recommended during pregnancy or breastfeeding, or in individuals with active cancer (NAD+ pathway upregulation is theorized to support tumor metabolism in some cancers, though this remains under study). Anyone with cardiac conditions or significant metabolic disease should be evaluated by a physician before starting NAD+ therapy.

Frequently asked questions

Is NAD+ FDA-approved?

No. NAD+ is not FDA-approved to treat or prevent any disease. Oral NR and NMN supplements are sold as dietary supplements under existing FDA supplement regulations. Compounded injectable and IV NAD+ are not FDA-approved drugs; they are administered under compounding pharmacy regulations.

Does NAD+ help with weight loss?

No good human evidence supports NAD+ supplementation as a weight-loss treatment. Published RCTs that measured body weight or composition showed no significant weight change with NR or NMN compared to placebo. NAD+ is not a GLP-1 agonist or appetite suppressant — it operates through fundamentally different cellular pathways.

What is the difference between NAD+, NMN, and NR?

NAD+ is the active coenzyme. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursor molecules your cells convert into NAD+. NR and NMN are available orally and have been shown to raise NAD+ in human studies. NAD+ itself is administered by IV or injection because it is not well absorbed orally. Which form, if any, produces the best clinical outcomes is not settled.

Can NAD+ reverse aging?

No human clinical trial has demonstrated that NAD+ supplementation reverses aging. Animal studies — including mouse and yeast models — show intriguing results, but mouse-to-human translation in aging biology is historically unreliable. Current human data confirm that NAD+ precursors raise NAD+ levels; meaningful, durable reversal of human aging phenotypes has not been demonstrated.

What does an IV NAD+ infusion feel like?

Many patients report feelings of increased energy or mental clarity during or shortly after an infusion. Rapid infusion commonly causes chest tightness, flushing, heart palpitations, and nausea. These effects usually ease when the rate is slowed. These subjective reports have not been validated in blinded clinical trials, so it is difficult to separate biological effects from expectation.

How long does it take to see results from NAD+ therapy?

Published clinical trials measuring NAD+ metabolites show elevation within hours to days of starting supplementation. Whether functional benefits (if any) follow a similar timeline is not established. Some providers use a loading protocol of several closely-spaced IV sessions, but the evidence base for any specific protocol is very limited.

Sources

  1. [1] Verdin E NAD⁺ in aging, metabolism, and neurodegeneration Science (2015). PMID 26785480
  2. [2] Rajman L, Chwalek K, Sinclair DA Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence Cell Metab (2018). PMID 29514064
  3. [3] Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans Nat Commun (2016). PMID 27721479
  4. [4] Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults Nat Commun (2018). PMID 29599478
  5. [5] Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures Cell Rep (2019). PMID 31412242
  6. [6] Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women Science (2021). PMID 33888596
  7. [7] Dollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobility Am J Clin Nutr (2018). PMID 29992272

Related peptides

Browse the full peptide directory, see what GLP-1s treat by condition, or compare the best GLP-1 providers.

Educational information only — not medical advice.